Patients’ Preference for a Specific Anti-Tumor Necrosis Factor Agent: Korea versus Western

참고문헌 (10)

1. 이강문, "Crohn’s disease in Korea: past, present, and future", The Korean Journal of Internal Medicine, 29(5), pp.558~570 (2014), 대한내과학회[DOI]
2. 박성철, "Current and Emerging Biologics for Ulcerative Colitis", Gut and Liver, 9(1), pp.18~27 (2015), 거트앤리버 발행위원회
3. Peyrin-Biroulet L, "Efficacy and safety of tumor necrosis factor antagonists in Crohn’s disease: meta-analysis of placebo-controlled trials", Clin Gastroenterol Hepatol, 6, pp.644~653 (2008)
4. Dignass A, "The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management", J Crohns Colitis, 4, pp.28~62 (2010)
5. Eun Soo Kim, "Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)", Gut and Liver, 10(3), pp.391~398 (2016), 거트앤리버 발행위원회
6. Vavricka SR, "Systematic assessment of factors influencing preferences of Crohn’s disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL)", Inflamm Bowel Dis, 18, pp.1523~1530 (2012)
7. Williams EL, "Patient preferences in choosing anti-TNF therapies-R1", Rheumatology, 45, pp.1575~1576 (2006)
8. Chilton F, "Treatment choices, preferences and decisionmaking by patients with rheumatoid arthritis", Musculoskeletal Care, 6, pp.1~14 (2008)
9. Scarpato S, "Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis: results from a questionnaire survey (RIVIERA study)", Rheumatology, 49, pp.289~294 (2010)
10. Huynh TK, "Preferences of patients and health professionals for route and frequency of administration of biologic agents in the treatment of rheumatoid arthritis", Patient Prefer Adherence, 8, pp.93~99 (2014)

관련 논문AI추천